{"id":"NCT00414908","sponsor":"Solvay Pharmaceuticals","briefTitle":"A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy","officialTitle":"A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-10","primaryCompletion":"2008-08","completion":"2009-12","firstPosted":"2006-12-22","resultsPosted":"2009-09-16","lastUpdate":"2011-08-10"},"enrollment":52,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Pancreatitis","Pancreatectomy","Pancreatic Exocrine Insufficiency"],"interventions":[{"type":"DRUG","name":"Pancrelipase delayed release capsule","otherNames":[]},{"type":"DRUG","name":"Placebo Comparator","otherNames":[]}],"arms":[{"label":"A","type":"EXPERIMENTAL"},{"label":"B","type":"PLACEBO_COMPARATOR"}],"summary":"This study assessed the effect of pancrelipase delayed release capsules on fat and nitrogen absorption in subjects with PEI due to Chronic Pancreatitis and Pancreatectomy. There was a run-in with a 5-day of single-blind placebo treatment, followed by a 7-day Double-blind period and a 6-month Open-Label Follow-up.","primaryOutcome":{"measure":"Change of Coefficient of Fat Absorption (CFA) (%) Between Baseline and End of Double-blind (DB) Period.","timeFrame":"End of double-blind period (5-7 days)","effectByArm":[{"arm":"Pancrelipase (DB)","deltaMin":31.93,"sd":18.57},{"arm":"Placebo (DB)","deltaMin":8.72,"sd":12.44}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":30,"countries":["United States","Bulgaria","Poland","Puerto Rico","Russia","Serbia","South Africa","Ukraine"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":24},"commonTop":["Upper respiratory Tract infections","Hyperglycaemic conditions NEC"]}}